Explore the full insider trade history of 리메드, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 리메드 has logged 7 reports. Market capitalisation: €84.4bn. The latest transaction was filed on 4 May 2026 — Other. Among the most active insiders: 이근용. The full history is accessible without an account.